Multi-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance
S. Alireza Rabi(Johns Hopkins University), Robert F. Siliciano(Johns Hopkins University), Liang Shan(Washington University in St. Louis), Stanley Chioma(Howard Hughes Medical Institute), Christine M. Durand(Johns Hopkins University), Sarah B. Laskey(Johns Hopkins University), Richard D. Moore(Harborview Medical Center), Gregory M. Laird(Duke Medical Center), Justin R. Bailey(Johns Hopkins University)
Cited by 140
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
Lipidomics reveals a remarkable diversity of lipids in human plasma
|Journal of Lipid Research|2010|1.3k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Defective proviruses rapidly accumulate during acute HIV-1 infection
|Nature Medicine|2016|774